Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Cocaine Dependence
NCT00689572Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Jul 2008
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ondansetron in cocaine dependence, sponsored by University of Virginia. Primary endpoint: Cocaine Use by Self-report at 9 weeks. Started Jul 2008; status: completed.
02
Drugs
ondansetron
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00689572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689572.